Table 2.
Final parameters of the joint model for the probability of avoiding a 30% decline of eGFR and ESRD
| Endpoints | Parameters | Coefficient (SE) | z value | P value | |
|---|---|---|---|---|---|
| 30% decline of eGFR | TKV model | ||||
| Intercept | 6.6684 | (0.0348) | 191.9 | <0.0001 | |
| Rate of growth | 0.0516 | (0.0024) | 21.8 | <0.0001 | |
| Event model | |||||
| Association (TKV→ event) | 0.8457 | (0.1204) | 7.02 | <0.0001 | |
| Baseline eGFR | 0.0101 | (0.0032) | 3.19 | 0.0014 | |
| Baseline age | 0.0004 | (0.0077) | 0.0519 | 0.9586 | |
| ESRD | TKV model | ||||
| Intercept | 6.712 | (0.0301) | 223.0 | <0.0001 | |
| Rate of growth | 0.0560 | (0.0020) | 28.4 | <0.0001 | |
| Event model | |||||
| Association (TKV→ event) | 1.2365 | (0.1631) | 7.58 | <0.0001 | |
| Baseline eGFR | −0.0391 | (0.0135) | −2.90 | 0.0037 | |
| Baseline age | 0.0355 | (0.0169) | 2.10 | 0.0357 | |
| eGFR:Age | −0.0012 | 0.0003 | −3.65 | 0.0003 | |
eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease; TKV, total kidney volume.